Haemonetics reported $33.01M in Net Income for its fiscal quarter ending in June of 2026.





Net Income Change Date
Baxter International USD 126M 141M Jun/2026
Becton, Dickinson and Co. USD 377M 688M Jun/2026
Boston Scientific USD 907M 434M Jun/2026
Cerus USD -20.92M 17.98M Dec/2024
Cooper Companies USD -77.9M 208.7M Mar/2026
Fresenius EUR 382M 53M Jun/2026
Fresenius Medical Care EUR 218.38M 100.38M Jun/2026
Globus Medical USD 151.57M 27.27M Jun/2026
Haemonetics USD 33.01M 53.16M Jun/2026
ICU Medical USD 19.09M 11.04M Jun/2026
Intuitive Surgical USD 818.1M 3.4M Jun/2026
Medtronic USD 1.24B 100M Mar/2026
Merit Medical Systems USD 41M 2.99M Mar/2026
Neogen USD -11.3M 5.7M Mar/2026
OraSure Technologies USD -19.29M 5.57M Dec/2025
Plus Therapeutics USD -6.95M 1.23M Mar/2026
Quidel USD -92.9M 1.1M Jun/2026
ResMed USD 383.43M 15.3M Jun/2026
STAAR Surgical USD 8.06M 2.85M Jun/2026
Steris USD 200.1M 20.2M Jun/2026
Stryker USD 1.28B 531M Jun/2026
Teleflex USD 99.69M 107.85M Jun/2026
Terumo JPY 70.43B 44.06B Jun/2026
Thermo Fisher Scientific USD 1.74B 85M Jun/2026
US Physical Therapy USD 9.9M 4.86M Jun/2026
Zimmer Biomet Holdings USD 198.3M 39.8M Jun/2026